An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on an online forum asked whether semaglutide might have caused their liver enzymes to rise. They said they began semaglutide in April at about 150 kg, lost 15 kg to reach 135 kg, and then found on recent blood tests that their AST (a liver enzyme) was higher than the normal range. They’re essentially asking: could the drug be linked to this lab change? Semaglutide is the active ingredient in medicines like Ozempic and Wegovy. It’s a man‑made version of a natural gut hormone that helps control appetite and blood sugar. People use it to help with weight loss and for diabetes. It doesn’t directly target the liver; instead it slows stomach emptying and signals the brain to reduce hunger, which typically leads to eating less and losing weight. What the snippet shows is an individual anecdote — one person reporting an elevated AST after months on semaglutide. That’s not the same as a controlled study. In clinical trials and post‑marketing reports, semaglutide has not been widely linked to serious liver injury, but mild elevations in liver enzymes have been reported occasionally with many medicines and with rapid weight loss itself. Because this is a single self‑report, we can’t tell whether the drug, the weight loss, other medicines, alcohol, underlying liver conditions, or lab variability caused the change. The size of the enzyme rise, whether other liver tests were abnormal, and whether it persisted or resolved are important details that aren’t provided. Why this matters: liver enzymes like AST and ALT are basic signals that doctors use to check liver health. A new elevation can prompt further tests or a pause of a medicine until the cause is known. If semaglutide were causing liver stress in some people, that would matter for prescribing decisions and monitoring plans. For a regular person considering or taking semaglutide, this means it’s reasonable to get routine blood tests and mention any symptoms (jaundice, dark urine, severe fatigue, abdominal pain) to a clinician. Caveats and risks: one anecdote does not prove causation. Many factors can raise liver enzymes — alcohol, viral hepatitis, fatty liver disease, other drugs or supplements, and even rapid weight loss can do this. Semaglutide is approved and generally considered safe, but like all drugs it can have side effects and should be used under medical supervision. If you or someone on the drug has abnormal liver tests, a clinician will usually repeat labs, check other tests (like ALT, bilirubin), review medications and alcohol use, and decide whether to stop the drug or investigate further. Regulatory labels and large studies have not shown widespread severe liver injury from semaglutide, but doctors remain cautious and monitor when needed. Bottom line: a single online report of higher AST after semaglutide is a signal worth checking out medically, not proof that the drug caused liver damage. If you’re on semaglutide and get abnormal liver tests, talk to your doctor for follow‑up.
Source: r/Semaglutide